Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39165

DNAJC1 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

DNAJC1 knockout HAP1 polyclonal cells are a CRISPR/Cas9-edited polyclonal knockout population derived from the near-haploid, chronic myeloid leukemia-origin HAP1 cell line. DNAJC1 recruits the chaperone HSPA8 to misfolded proteins for refolding or ER-associated degradation (ERAD), with its expression regulated by HSF1 and ER stress sensors IRE1, ATF6, and PERK. Key pathway partners include HSPA5 (BiP), DERL1, and VCP. This knockout model is ideal for investigating protein quality control, ER stress responses, and cancer cell proteostasis. Applications span functional genomics, haploid genetic screens, and assays such as western blotting, immunofluorescence, and viability analysis under ER stress conditions.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    DNAJC1

    Gene Identifier

    NCBI Gene ID 64215

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC1 knockout HAP1 polyclonal cells provide a heterogeneous pool of CRISPR/Cas9-edited HAP1 cells carrying targeted disruptions of the DNAJC1 gene. This polyclonal knockout population, generated by CRISPR/Cas9-mediated gene disruption, offers a robust tool for studying DNAJC1-dependent functions without the bias of clonal selection. The mixture of loss-of-function alleles recapitulates natural variation in knockout efficiency and is well-suited for phenotypic analyses where averaging across multiple edits mitigates clone-specific artifacts.

HAP1 is a near-haploid, fibroblast-like adherent cell line derived from the chronic myeloid leukemia KBM-7 line. Its near-haploid karyotype simplifies genetic manipulation because disruption of a single allele typically yields a complete loss-of-function phenotype. HAP1 cells retain signaling networks characteristic of myeloid leukemia, including active stress response and protein quality control pathways. Their robust growth and amenability to high-throughput screening make them a preferred system for functional genomics and CRISPR-based studies.

DNAJC1 encodes a co-chaperone that recruits HSPA8 to misfolded proteins, shuttling them towards refolding or ER-associated degradation (ERAD). The expression of DNAJC1 is controlled by heat shock factor 1 (HSF1) and ER stress transducers IRE1, ATF6, and PERK. DNAJC1 associates with HSPA8, DnaJ/Hsp40 family members, and ERAD components like DERL1 and VCP. Downstream, DNAJC1 facilitates the processing of HSPA8 clients and ERAD substrates; its loss leads to accumulation of misfolded polypeptides and activation of the unfolded protein response. Representative pathway nodes include HSPA5 (BiP), DERL1, and VCP, which collaborate with DNAJC1 to maintain proteostasis. Thus, DNAJC1 serves as a critical link between cytosolic chaperone machinery and ER quality control.

In HAP1 cells, DNAJC1 knockout perturbs the balance between chaperone-mediated refolding and degradation, creating a state of heightened proteotoxic stress and UPR engagement. Because HAP1 cells originate from CML, this model enables investigation of how leukemia-derived cells manage protein misfolding and whether they rely on specific proteostasis factors for survival. The near-haploid background ensures that phenotypes such as ER stress sensitivity and ubiquitinated protein accumulation are directly linked to DNAJC1 disruption, facilitating clear mechanistic interpretations.

This polyclonal knockout model is suited for functional genomics, protein homeostasis research, and ER stress studies. Typical assays include western blotting and RT-qPCR for UPR markers (e.g., BiP, CHOP), immunofluorescence for aggregation, and viability assays under ER stress-inducing drugs like tunicamycin. The polyclonal design supports haploid genetic screens to identify synthetic lethal interactions or modifiers of DNAJC1 function. Co-immunoprecipitation can still be applied to probe residual network interactions. For detailed product inquiries, please reach out to Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)